Literature DB >> 29133347

Analysis of the Human Mucosal Response to Cholera Reveals Sustained Activation of Innate Immune Signaling Pathways.

Firdausi Qadri1, Jason B Harris2,3, Daniel L Bourque4,5, Taufiqur Rahman Bhuiyan6, Diane P Genereux7,8, Rasheduzzaman Rashu6, Crystal N Ellis4, Fahima Chowdhury6, Ashraful I Khan6, Nur Haq Alam6, Anik Paul6, Lazina Hossain6, Leslie M Mayo-Smith4, Richelle C Charles4,5, Ana A Weil4,5, Regina C LaRocque4,5, Stephen B Calderwood4,5,9, Edward T Ryan4,5,10, Elinor K Karlsson7,8.   

Abstract

To better understand the innate immune response to Vibrio cholerae infection, we tracked gene expression in the duodenal mucosa of 11 Bangladeshi adults with cholera, using biopsy specimens obtained immediately after rehydration and 30 and 180 days later. We identified differentially expressed genes and performed an analysis to predict differentially regulated pathways and upstream regulators. During acute cholera, there was a broad increase in the expression of genes associated with innate immunity, including activation of the NF-κB, mitogen-activated protein kinase (MAPK), and Toll-like receptor (TLR)-mediated signaling pathways, which, unexpectedly, persisted even 30 days after infection. Focusing on early differences in gene expression, we identified 37 genes that were differentially expressed on days 2 and 30 across the 11 participants. These genes included the endosomal Toll-like receptor gene TLR8, which was expressed in lamina propria cells. Underscoring a potential role for endosomal TLR-mediated signaling in vivo, our pathway analysis found that interferon regulatory factor 7 and beta 1 and alpha 2 interferons were among the top upstream regulators activated during cholera. Among the innate immune effectors, we found that the gene for DUOX2, an NADPH oxidase involved in the maintenance of intestinal homeostasis, was upregulated in intestinal epithelial cells during cholera. Notably, the observed increases in DUOX2 and TLR8 expression were also modeled in vitro when Caco-2 or THP-1 cells, respectively, were stimulated with live V. cholerae but not with heat-killed organisms or cholera toxin alone. These previously unidentified features of the innate immune response to V. cholerae extend our understanding of the mucosal immune signaling pathways and effectors activated in vivo following cholera.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  Vibrio cholerae; immune mechanisms; mucosal immunity

Mesh:

Year:  2018        PMID: 29133347      PMCID: PMC5778365          DOI: 10.1128/IAI.00594-17

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  40 in total

Review 1.  Cholera.

Authors:  Jason B Harris; Regina C LaRocque; Firdausi Qadri; Edward T Ryan; Stephen B Calderwood
Journal:  Lancet       Date:  2012-06-30       Impact factor: 79.321

2.  Ultrastructural changes in the upper small intestinal mucosa in patients with cholera.

Authors:  M M Mathan; G Chandy; V I Mathan
Journal:  Gastroenterology       Date:  1995-08       Impact factor: 22.682

3.  Genetic modulation of TLR8 response following bacterial phagocytosis.

Authors:  Michael P Gantier; Aaron T Irving; Maria Kaparakis-Liaskos; Dakang Xu; Vanessa A Evans; Paul U Cameron; James A Bourne; Richard L Ferrero; Matthias John; Mark A Behlke; Bryan R G Williams
Journal:  Hum Mutat       Date:  2010-09       Impact factor: 4.878

4.  Acute dehydrating disease caused by Vibrio cholerae serogroups O1 and O139 induce increases in innate cells and inflammatory mediators at the mucosal surface of the gut.

Authors:  F Qadri; T R Bhuiyan; K K Dutta; R Raqib; M S Alam; N H Alam; A-M Svennerholm; M M Mathan
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

5.  Magnitude, kinetics, and duration of vibriocidal antibody responses in North Americans after ingestion of Vibrio cholerae.

Authors:  M L Clements; M M Levine; C R Young; R E Black; Y L Lim; R M Robins-Browne; J P Craig
Journal:  J Infect Dis       Date:  1982-04       Impact factor: 5.226

Review 6.  Critical analysis of compositions and protective efficacies of oral killed cholera vaccines.

Authors:  Shahjahan Kabir
Journal:  Clin Vaccine Immunol       Date:  2014-07-23

7.  Differential modulation of NF-kappaB-mediated pro-inflammatory response in human intestinal epithelial cells by cheY homologues of Vibrio cholerae.

Authors:  Arunava Bandyopadhaya; Keya Chaudhuri
Journal:  Innate Immun       Date:  2009-06       Impact factor: 2.680

8.  Vibrio cholerae cytolysin causes an inflammatory response in human intestinal epithelial cells that is modulated by the PrtV protease.

Authors:  Gangwei Ou; Pramod Kumar Rompikuntal; Aziz Bitar; Barbro Lindmark; Karolis Vaitkevicius; Sun Nyunt Wai; Marie-Louise Hammarström
Journal:  PLoS One       Date:  2009-11-12       Impact factor: 3.240

Review 9.  TLR8: the forgotten relative revindicated.

Authors:  Jorge L Cervantes; Bennett Weinerman; Chaitali Basole; Juan C Salazar
Journal:  Cell Mol Immunol       Date:  2012-10-22       Impact factor: 11.530

10.  TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions.

Authors:  Daehwan Kim; Geo Pertea; Cole Trapnell; Harold Pimentel; Ryan Kelley; Steven L Salzberg
Journal:  Genome Biol       Date:  2013-04-25       Impact factor: 13.583

View more
  13 in total

1.  Microbiota-Associated Biofilm Regulation Leads to Vibrio cholerae Resistance Against Intestinal Environmental Stress.

Authors:  Jennifer Y Cho; Rui Liu; Ansel Hsiao
Journal:  Front Cell Infect Microbiol       Date:  2022-04-27       Impact factor: 6.073

2.  DksA coordinates bile-mediated regulation of virulence-associated phenotypes in type three secretion system-positive Vibrio cholerae.

Authors:  Madeline K Sofia; Michelle Dziejman
Journal:  Microbiology (Reading)       Date:  2021-02       Impact factor: 2.777

3.  Requirement for Cyclic AMP/Protein Kinase A-Dependent Canonical NFκB Signaling in the Adjuvant Action of Cholera Toxin and Its Non-toxic Derivative mmCT.

Authors:  Manuela Terrinoni; Jan Holmgren; Michael Lebens; Maximilian Larena
Journal:  Front Immunol       Date:  2019-02-19       Impact factor: 7.561

Review 4.  Vibrio cholerae at the Intersection of Immunity and the Microbiome.

Authors:  Ana A Weil; Rachel L Becker; Jason B Harris
Journal:  mSphere       Date:  2019-11-27       Impact factor: 4.389

5.  Cholera: Immunity and Prospects in Vaccine Development.

Authors:  Jason B Harris
Journal:  J Infect Dis       Date:  2018-10-15       Impact factor: 5.226

6.  Posttranslational Regulation of IL-23 Production Distinguishes the Innate Immune Responses to Live Toxigenic versus Heat-Inactivated Vibrio cholerae.

Authors:  Ana A Weil; Crystal N Ellis; Meti D Debela; Taufiqur R Bhuiyan; Rasheduzzaman Rashu; Daniel L Bourque; Ashraful I Khan; Fahima Chowdhury; Regina C LaRocque; Richelle C Charles; Edward T Ryan; Stephen B Calderwood; Firdausi Qadri; Jason B Harris
Journal:  mSphere       Date:  2019-08-21       Impact factor: 4.389

7.  Pathogenicity and virulence regulation of Vibrio cholerae at the interface of host-gut microbiome interactions.

Authors:  Ansel Hsiao; Jun Zhu
Journal:  Virulence       Date:  2020-12       Impact factor: 5.882

Review 8.  Bacteria That Cause Enteric Diseases Stimulate Distinct Humoral Immune Responses.

Authors:  Souwelimatou Amadou Amani; Mark L Lang
Journal:  Front Immunol       Date:  2020-09-16       Impact factor: 7.561

Review 9.  Virulence Regulation and Innate Host Response in the Pathogenicity of Vibrio cholerae.

Authors:  Thandavarayan Ramamurthy; Ranjan K Nandy; Asish K Mukhopadhyay; Shanta Dutta; Ankur Mutreja; Keinosuke Okamoto; Shin-Ichi Miyoshi; G Balakrish Nair; Amit Ghosh
Journal:  Front Cell Infect Microbiol       Date:  2020-09-30       Impact factor: 5.293

10.  Gut Microbiota and Development of Vibrio cholerae-Specific Long-Term Memory B Cells in Adults after Whole-Cell Killed Oral Cholera Vaccine.

Authors:  Firdausi Qadri; Ana A Weil; Denise Chac; Taufiqur R Bhuiyan; Amit Saha; Mohammad M Alam; Umme Salma; Nusrat Jahan; Fahima Chowdhury; Ashraful I Khan; Edward T Ryan; Regina LaRocque; Jason B Harris
Journal:  Infect Immun       Date:  2021-08-16       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.